Methodology Suitable (methodology + suitable)

Distribution by Scientific Domains


Selected Abstracts


Hydroacoustic target strength validation using angling creel census data

FISHERIES MANAGEMENT & ECOLOGY, Issue 6 2002
P. A. FREAR
Validation of hydroacoustic in-situ target strength is problematic in large, deep lowland rivers, which cannot be sampled easily by conventional methods such as netting or electric fishing. A sampling programme involving three different techniques (split beam sonar, angling census and post-angling competition data collection) was conducted to examine methodologies suitable for target strength validation. This combination of techniques also assessed the relative merits of each method for best describing fish populations and the stocks exploited in a recreational coarse fishery. The sonar estimated the greatest number of fish of the three techniques, with a strong positive size correlation with the other two methods. The angling census and post-competition census accounted for more larger fish, >26 cm, than were detected acoustically, indicating a stratification of species that were exploited by angling but not detected by horizontal sonar. The combined techniques demonstrated a suitable, cost-effective, hydroacoustic validation method for large UK rivers, which supports recreational coarse fisheries management, with the added advantage of species identification. [source]


New method for age estimation of developmental defects of enamel formation in living populations

AMERICAN JOURNAL OF HUMAN BIOLOGY, Issue 4 2010
Rhonda Gillett-Netting
Histologically based age of occurrence estimates for developmental defects of enamel (DDE) are raising questions about the continued utility of traditional macroscopic methods; however, the new techniques are not appropriate for use on living populations. This study, using methodology suitable for noninvasive use on living populations, compares assignment of defect timing using a histologically informed macroscopic method (HIMM) versus traditional methodology (TM). For this Southern African population, TM estimates later median age of DDE occurrence than HIMM (Z -score: ,13.565, P < 0.000) and modal age is 1 year earlier. HIMM allows for continued collection of DDE in living populations with the added benefit of more precise timing of enamel development. Accuracy for estimating general stressors during childhood is necessary for construction of diachronic analyses. Am. J. Hum. Biol., 2010. © 2010 Wiley-Liss, Inc. [source]


Differential protein expression between normal, early-stage, and late-stage myxomatous mitral valves from dogs

PROTEOMICS - CLINICAL APPLICATIONS, Issue 12 2009
Carla M. R. Lacerda
Abstract Valvular heart disease accounts for over 20,000 deaths and 90,000 hospitalizations yearly in the United States. Myxomatous valve disease (MVD) is the most common disease of the mitral valve in humans and dogs. MVD is pathologically identical in these species and its pathogenesis is poorly understood. The objectives of this study were to (i) develop proteomic methodology suitable for analysis of extracellular matrix-rich heart valve tissues and (ii) survey over- and under-expressed proteins that could provide mechanistic clues into the pathogenesis of MVD. Normal, early-stage, and late-stage myxomatous mitral valves from dogs were studied. A shotgun proteomic analysis was used to quantify differential protein expression. Proteins were classified by function and clustered according to differential expression patterns. More than 300 proteins, with 117 of those being differentially expressed, were identified. Hierarchical sample clustering of differential protein profiles showed that early- and late-stage valves were closely related. This finding suggests that proteome changes occur in early degeneration stages and these persist in late stages, characterizing a diseased proteome that is distinct from normal. Shotgun proteome analysis of matrix-rich canine heart valves is feasible, and should be applicable to human heart valves. This study provides a basis for future investigations into the pathogenesis of MVD. [source]


A critical appraisal of lithium's efficacy and effectiveness: the last 60 years

BIPOLAR DISORDERS, Issue 2009
Paul Grof
The history that depicts the evaluation of lithium's efficacy presents an interesting contrast: on the one hand, conviction that, of all psychotropic drugs, lithium has the best demonstrated efficacy; on the other hand, repeated attempts to question it. Those contesting lithium's stabilizing abilities have argued from several angles, for example that the proof was methodologically incorrect or insufficient, that the number of responders is small, or that the response is poor in practice and does not last. But there is a good explanation for this paradox. While the early challenges to lithium's value in recurrent mood disorders reflected mainly that psychiatry had not yet developed a methodology suitable for testing long-term efficacy, more recent questioning has resulted mostly from retesting its efficacy and effectiveness in a substantially broadened bipolar spectrum, outside the classical diagnosis. Lithium, however, continues to stabilize very well the patients suffering from typical bipolar disorder,the condition for which its efficacy was originally demonstrated. More recently, lithium has also proven to dramatically reduce suicidal behavior and mortality and to augment markedly the efficacy of antidepressants in unresponsive patients. [source]